Publications by authors named "M Elkassaby"

Objectives: Zygomatic implant surgery can be difficult due to the limited intraoperative visibility of the surgical field and the complex anatomy of the zygomatic bone, which could lead to serious complications. This study aims to assess the accuracy of zygomatic implants placement using computer-guided surgical templates.

Materials And Methods: A total of 13 zygomatic implants were placed in four participants.

View Article and Find Full Text PDF

Introduction: Early dental implant failure (EDIF) can occur even when optimal materials are used, surgical protocols are strictly followed and the quantity and quality of bone at the recipient site are sufficient. The existence of specific patient-related risk factors require an investigation into the regulatory mechanisms controlling bone metabolism, bone remodelling and bone turnover as well as serum Vitamin D. The implant stability quotient is used as a prognostic indicator for possible implant failure.

View Article and Find Full Text PDF

Introduction: Chronic kidney disease (CKD) affects 13% of the global population and requires renal replacement therapy due to ESRD. Hemodialysis (HD) is the most common dialysis modality for ESRD patients, but establishing vascular access is challenging due to high morbidity and mortality rates. Arteriovenous fistulas (AVFs) are the gold standard for vascular access, but many fail due to anastomotic hemodynamics, vein diameter, and anastomatic suture technique.

View Article and Find Full Text PDF

The aim of this study was to review current literature regarding the speech outcome of different techniques of surgical treatment of VPD in cleft patients, in an attempt to reach a treatment algorithm. A systematic review was done, by searching Pubmed, Scopus, and Web of Science electronic databases, following the PRISMA guidelines. Articles reporting speech assessment results of secondary VPI surgeries on non-syndromic patients with CP.

View Article and Find Full Text PDF

Background: Saccharomyces cerevisiae (S. cerevisiae) has been demonstrated in vitro to sensitize several breast cancer cell lines and to be a safe, non-toxic drug with anti-skin cancer action in mice. Furthermore, plasmonic photothermal treatment using gold nanorods has been authorized as a novel method for in vitro and in vivo cancer therapy.

View Article and Find Full Text PDF